Search

Nicholas S Mitsiades

from Sacramento, CA
Age ~52
Get Report
Also known as:
Nick Mitsiades, Nicholas Poulaki
Related to:
Constantine S Mitsiades, 50Fani Poulaki, 74
Connected to:
Margarita D Mitsios, 42Nicholas K Mitsis, 50Thanasis I Mitsolides, 60Amy L Mitson, 50Marcus A Mitson, 41Estelle D Mitsopoulos, 64Karen A Mitsopoulos, 50Cary Mitsos, 74John E Mitsotakis, 51Aaron J Mitstifer, 47

Nicholas Mitsiades Phones & Addresses

  • Sacramento, CA
  • 6540 Bellows Ln, Houston, TX 77030 (713) 799-2215
  • 400 Brookline St, Roxbury, MA 02215 (617) 731-0215
  • 14 Loyola Cir, West Roxbury, MA 02132 (617) 325-9173
  • 24 Pinehurst St, Roslindale, MA 02131 (617) 325-9173
  • Boston, MA
  • Dedham, MA
  • New York, NY
  • Framingham, MA
  • Brookline, MA
  • 400 Brookline Ave, Boston, MA 02215 (617) 733-2815

Work

Company: Baylor Coll Medcn Hmtlgy Onclgy Address: 1 Baylor Plz Suite Bcm187, Houston, TX 77030 Phones: (713) 798-7535

Education

School / High School: Memorial Sloan - Kettering Cancer Center

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Diabetes, Metabolism & Endocrinology, 2009

Specialities

Endocrinology, Diabetes & Metabolism • Medical Oncology • Oncology

Professional Records

Medicine Doctors

Nicholas Mitsiades Photo 1

Dr. Nicholas Mitsiades, Houston TX - MD (Doctor of Medicine)

View page
Specialties:
Endocrinology, Diabetes & Metabolism
Medical Oncology
Oncology
Address:
Baylor Coll Medcn Hmtlgy Onclgy
1 Baylor Plz Suite Bcm187, Houston, TX 77030
(713) 798-7535 (Phone)
Certifications:
Diabetes, Metabolism & Endocrinology, 2009
Internal Medicine, 2006
Medical Oncology, 2010
Awards:
Healthgrades Honor Roll
Languages:
English
Nicholas Mitsiades Photo 2

Nicholas Mitsiades

View page
Specialties:
Hematology/Oncology
Work:
Baylor College Of MedicineBaylor College Of Medicine Hematology & Oncology
1 Baylor Plz Bcm620, Houston, TX 77030
(713) 798-7535 (phone), (713) 798-6677 (fax)
Education:
Medical School
Univ Athens, Fac Med, Sch of Hlth Sci, Nat'l & Kapodistrian, Athens
Graduated: 1995
Procedures:
Chemotherapy
Conditions:
Acute Renal Failure
Anemia
Bacterial Pneumonia
Bladder Cancer
Conduction Disorders
Languages:
English
Spanish
Description:
Dr. Mitsiades graduated from the Univ Athens, Fac Med, Sch of Hlth Sci, Nat'l & Kapodistrian, Athens in 1995. He works in Houston, TX and specializes in Hematology/Oncology. Dr. Mitsiades is affiliated with Baylor St Lukes Medical Center, Harris Health System Ben Taub Hospital and Houston Methodist Hospital.
Nicholas Mitsiades Photo 3

Nicholas Mitsiades, Houston TX

View page
Specialties:
Internal Medicine
Medical Oncology
Endocrinology, Diabetes & Metabolism
Hematology & Oncology
Endocrinology and Metabolism
Work:
Baylor College of Medicine
6620 Main St, Houston, TX 77030
MS: BCM 390; Baylor College of
1 Baylor Plz, Houston, TX 77030
Education:
University Of Athens (1995)
Nicholas Mitsiades Photo 4

Nicholas Mitsiades, Houston TX

View page
Specialties:
Oncologist
Address:
1 Baylor Plz, Houston, TX 77030
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
American Board of Internal Medicine Sub-certificate in Endocrinology, Diabetes, and Metabolism (Internal Medicine)
American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)

Resumes

Resumes

Nicholas Mitsiades Photo 5

Associate Professor

View page
Location:
Houston, TX
Work:
Baylor College of Medicine
Associate Professor
Education:
Memorial Sloan - Kettering Cancer Center

Business Records

Name / Title
Company / Classification
Phones & Addresses
Nicholas Mitsiades
Nicholas Mitsiades MD,PHD
Internist
6620 Main St, Houston, TX 77030
(713) 798-2500

Publications

Us Patents

Methods And Compositions For Treating Cancer Using Proteasome Inhibitors

View page
US Patent:
8026230, Sep 27, 2011
Filed:
Apr 29, 2005
Appl. No.:
11/119473
Inventors:
Kenneth C. Anderson - Wellesley MA, US
Teru Hideshima - Brookline MA, US
Constantine S. Mitsiades - Boston MA, US
Nicholas Mitsiades - Framingham MA, US
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
A61K 38/08
A61K 38/05
A61K 31/04
US Classification:
514183, 514 34, 514 16, 514 18
Abstract:
The present invention relates to therapeutic compositions for treating cancer or preventing the growth of cancer cells, e. g. , tumor growth, in a subject. The present invention also relates to methods for treating cancer, e. g. , inhibiting tumor growth, in a subject who has become resistant to treatment, by administering to a subject an effective amount of a proteasome inhibitor and an effective amount of a therapeutic agent, e. g. , a chemotherapeutic agent. The present invention further relates to methods for purging bone marrow, i. e. , removing cancer cells from bone marrow, by exposing the bone marrow cells to a proteasome inhibitor and a therapeutic agent, e. g. , a chemotherapeutic agent.

Use Of Reversine And Analogs For Treatment Of Cancer

View page
US Patent:
8466147, Jun 18, 2013
Filed:
Nov 12, 2007
Appl. No.:
12/514360
Inventors:
Kenneth C. Anderson - Wellesley MA, US
Nicholas Mitsiades - Roxbury MA, US
Joseph Negri - Jamaica Plain MA, US
Douglas W. McMillin - Cambridge MA, US
Constantine S. Mitsiades - Boston MA, US
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
A61K 31/52
US Classification:
5142342
Abstract:
Herein is provided methods and compositions for treating cancer. In one embodiment, a method is provided for treating a patient suffering from cancer, the method comprising administering to the patient an effective amount of reversine, reversine analog or reversine containing agent. In another embodiment, compositions comprising reversine are provided. Such compositions may further comprise additional active agents and other additives. The compositions and methods provided herein are useful, for example, in the area of medicine.

Aplidine For Multiple Myeloma Treatment

View page
US Patent:
20060172926, Aug 3, 2006
Filed:
Mar 12, 2004
Appl. No.:
10/548710
Inventors:
Joseph Bertino - Branford CT, US
Daniel Medina - Hampton NJ, US
Glynn Faircloth - Cambridge MA, US
Constantine Mitsiades - Boston MA, US
Kenneth Anderson - Wallesley MA, US
Nicholas Mitsiades - West Roxbury MA, US
International Classification:
A61K 38/12
C07K 7/60
US Classification:
514010000, 530317000
Abstract:
Aplidine and aplidine analogues are used in the manufacture of a medicament for treating multiple myeloma.

Cell Co-Culture Systems And Uses Thereof

View page
US Patent:
20100255999, Oct 7, 2010
Filed:
Feb 1, 2008
Appl. No.:
12/525394
Inventors:
Constantine S. Mitsiades - Boston MA, US
Douglas W. McMillin - Cambridge MA, US
Joseph M. Negri - Jamaica Plain MA, US
Nicholas Mitsiades - Roxbury MA, US
Kenneth C. Anderson - Wellesley MA, US
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
C40B 20/00
C40B 60/12
C12N 5/00
C12N 5/09
US Classification:
506 2, 506 39, 435404, 435325
Abstract:
The invention provides a cell co-culture for the selective evaluation of the response of a cell of interest in the co-culture, and methods of using the co-culture. The cell co-culture and the methods are suitable for large-scale/high throughput screening for compounds useful for affecting at least one biological function or event of at least one cell type in the co-culture. The invention further provides kits for using the screening assays.

Treatment Of Multiple Myeloma

View page
US Patent:
20100286090, Nov 11, 2010
Filed:
Nov 14, 2006
Appl. No.:
12/084657
Inventors:
Constantine S Mitsiades - Boston MA, US
Qingwei Deng - Watertown MA, US
Nicholas S. Mitsiades - West Roxbury MA, US
Kenneth C. Anderson - Wellesley MA, US
Joseph Negri - E. Falmouth MA, US
International Classification:
A61K 31/69
A61K 31/573
A61K 31/506
A61P 35/00
US Classification:
514 64, 514171, 51425219
Abstract:
Methods for treating multiple myeloma comprising administering a therapeutically effective amount of dasatinib to a patient in need of treatment thereof. Dasatinib can be administered alone or in combination with a second anti-neoplastic agent such as dexamethasone or bortezomib. The patient may be refractory to prior treatment with an anti-neoplastic agent other than dasatinib.

Methods And Compositions For Treating Cancer Using Proteasome Inhibitors

View page
US Patent:
20120214757, Aug 23, 2012
Filed:
Sep 23, 2011
Appl. No.:
13/242209
Inventors:
Kenneth C. Anderson - Wellesley MA, US
Teru Hideshima - Brookline MA, US
Constantine S. Mitsiades - Boston MA, US
Nicholas Mitsiades - Roxbury MA, US
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
A61K 31/69
A61K 31/197
A61P 35/00
A61K 31/704
US Classification:
514 34, 514564, 514 64
Abstract:
The present invention relates to therapeutic compositions for treating cancer or preventing the growth of cancer cells, e.g., tumor growth, in a subject. The present invention also relates to methods for treating cancer, e.g., inhibiting tumor growth, in a subject who has become resistant to treatment, by administering to a subject an effective amount of a proteasome inhibitor and an effective amount of a therapeutic agent, e.g., a chemotherapeutic agent. The present invention further relates to methods for purging bone marrow, i.e., removing cancer cells from bone marrow, by exposing the bone marrow cells to a proteasome inhibitor and a therapeutic agent, e.g., a chemotherapeutic agent.

Cell Co-Culture Systems And Uses Thereof

View page
US Patent:
20130274142, Oct 17, 2013
Filed:
Mar 13, 2013
Appl. No.:
13/799615
Inventors:
Douglas W. McMillin - Cambridge MA, US
Joseph M. Negri - Jamaica Plain MA, US
Nicholas Mitsiades - Roxbury MA, US
Kenneth C. Anderson - Wellesley MA, US
International Classification:
G01N 33/50
US Classification:
506 10
Abstract:
The invention provides a cell co-culture for the selective evaluation of the response of a cell of interest in the co-culture, and methods of using the co-culture. The cell co-culture and the methods are suitable for large-scale/high throughput screening for compounds useful for affecting at least one biological function or event of at least one cell type in the co-culture. The invention further provides kits for using the screening assays.

Cell Co-Culture Systems And Uses Thereof

View page
US Patent:
20190011433, Jan 10, 2019
Filed:
Feb 5, 2018
Appl. No.:
15/888734
Inventors:
- Boston MA, US
Douglas W. McMillin - Cambridge MA, US
Joseph M. Negri - Jamaica Plain MA, US
Nicholas Mitsiades - Roxbury MA, US
Kenneth C. Anderson - Wellesley MA, US
International Classification:
G01N 33/50
C12M 1/42
Abstract:
The invention provides a cell co-culture for the selective evaluation of the response of a cell of interest in the co-culture, and methods of using the co-culture. The cell co-culture and the methods are suitable for large-scale/high throughput screening for compounds useful for affecting at least one biological function or event of at least one cell type in the co-culture. The invention further provides kits for using the screening assays.
Control profile
Nicholas S Mitsiades from Sacramento, CA, age ~52 Get Report